Suspended PHASE2 INTERVENTIONAL NCT00299585

A Clinical Study of the Use of Brushite as Primary Stabilizer in Immediate Dental Implantation

Phase 2 Clinical Study on the Efficacy of Injectable Brushite Bone Cement in Bone Augmentation and Dental Implant Stabilization

Sponsor: Hadassah Medical Organization

Conditions Alveolar Ridge Augmentation Dental Implants

Interventions using PD VitalOs Cement with dental implants

Updated 7 times since 2017 Last updated: Jan 5, 2010 Started: Dec 31, 2007 Primary completion: May 31, 2008 Completion: Nov 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

manufacturer could not finance the study

Listed as NCT00299585, this PHASE2 trial focuses on Alveolar Ridge Augmentation and Dental Implants and remains suspended. Sponsored by Hadassah Medical Organization, it has been updated 7 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Suspended PHASE2
Sep 2024 — Sep 2025 [monthly]

Suspended PHASE2
Jul 2024 — Sep 2024 [monthly]

Suspended PHASE2
Jan 2021 — Jul 2024 [monthly]

Suspended PHASE2
Jun 2018 — Jan 2021 [monthly]

Suspended PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Suspended PHASE2
Jan 2017 — Feb 2017 [monthly]

Suspended PHASE2

First recorded

Dec 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hadassah Medical Organization

Data source: Hadassah Medical Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jerusalem, Israel